Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06319495

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

A Randomized Controlled Trial For Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Sponsor: Copka Sonpashan

Conditions Cerebral Small Vessel Diseases

Interventions Lidocaine Hydrochloride Rehabilitation therapy Stellate ganglion block placebo injection

Updated 3 times since 2024 Last updated: Mar 19, 2024 Started: Mar 31, 2024 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cerebral Small Vessel Diseases, this trial is actively recruiting participants. The trial is conducted by Copka Sonpashan and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Copka Sonpashan

Data source: Chao Phya Abhaibhubejhr Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.